We are live on ! Find out more
BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

33 hedge funds and large institutions have $21.7M invested in ProShares Ultra NASDAQ Biotechnology in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

3% more funds holding

Funds holding: 32 → 33 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.4% less ownership

Funds ownership: 6.84% → 4.44% (-2.4%)

17% less capital invested

Capital invested by funds: $26.1M → $21.7M (-$4.39M)

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

57% less call options, than puts

Call options by funds: $10.4M | Put options by funds: $24.6M

Holders
33
Holders Change
+1
Holders Change %
+3.13%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
8
Reduced
12
Closed
5
Calls
$10.4M
Puts
$24.6M
Net Calls
-$14.1M
Net Calls Change
-$12.4M

Top Buyers

1
GWM
Geneos Wealth Management
Colorado
+$1.84M
2
Simplex Trading
Simplex Trading
Illinois
+$520K
3
Citadel Advisors
Citadel Advisors
Florida
+$432K
4
TFA
Toth Financial Advisory
Virginia
+$331K
5
CIA
Capital Investment Advisors
Georgia
+$258K

Top Sellers

1
RIA
RPG Investment Advisory
California
-$5.02M
2
TRCT
Tower Research Capital (TRC)
New York
-$1.54M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.35M
4
BG
Bellevue Group
Switzerland
-$1.01M
5
PCA
Private Capital Advisors
Connecticut
-$569K
Name Holding Trade Value Shares
Change 		Change in
Stake
OPPM
1
Opus Point Partners Management
New York
$7.99M – – –
CIC
2
Chase Investment Counsel
Virginia
$2.84M – – –
GWM
3
Geneos Wealth Management
Colorado
$1.99M +$1.84M +32,300 +17,650%
TFA
4
Toth Financial Advisory
Virginia
$1.7M +$331K +5,821 +26%
BA
5
BKS Advisors
Michigan
$1.45M – – –
Citadel Advisors
6
Citadel Advisors
Florida
$925K +$432K +7,600 +101%
BRC
7
Bell Rock Capital
Delaware
$677K -$171K -3,000 -21%
SBIA
8
Sheaff Brock Investment Advisors
Indiana
$620K -$2.84K -50 -0.5%
PCA
9
Private Capital Advisors
Connecticut
$612K -$569K -10,004 -50%
Simplex Trading
10
Simplex Trading
Illinois
$560K +$520K +9,149 New
Koshinski Asset Management
11
Koshinski Asset Management
Illinois
$433K +$12.1K +213 +3%
Creative Planning
12
Creative Planning
Kansas
$321K +$122K +2,138 +69%
CIA
13
Capital Investment Advisors
Georgia
$278K +$258K +4,545 New
SPC
14
Sigma Planning Corp
Michigan
$251K -$42.5K -748 -15%
TCM
15
Traynor Capital Management
Pennsylvania
$223K +$211K +3,712 New
LPL Financial
16
LPL Financial
California
$217K -$25.9K -455 -11%
RIA
17
RPG Investment Advisory
California
$212K -$5.02M -88,272 -96%
CAL
18
Capital Analysts LLC
Pennsylvania
$106K – – –
Morgan Stanley
19
Morgan Stanley
New York
$105K -$367K -6,462 -79%
ASN
20
Advisory Services Network
Georgia
$59K -$2.5K -44 -4%
SJIM
21
St. Johns Investment Management
Florida
$55K +$51.5K +905 New
Bank of America
22
Bank of America
North Carolina
$37K -$56.9K -1,000 -63%
IA
23
IFP Advisors
Florida
$17K -$41.2K -725 -73%
CAPTRUST Financial Advisors
24
CAPTRUST Financial Advisors
North Carolina
$10K +$4.55K +80 +80%
VFA
25
Valeo Financial Advisors
Indiana
$8K +$7.33K +129 New
1
2

BIB Hedge Fund Activity: Q3 2017 in Review

33 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra NASDAQ Biotechnology (BIB) for Q3 2017, worth a combined $21.7M — down 17% from $26.1M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new BIB positions and 5 closed out — a net gain of 3 holders — while 8 added to existing stakes and 12 trimmed.

The largest buyer was Geneos Wealth Management, adding an estimated $1.84M. The largest seller was RPG Investment Advisory, cutting an estimated $5.02M.

  • 33 institutional investors held ProShares Ultra NASDAQ Biotechnology (BIB) as of Q3 2017, up from 32 in Q2 2017.
  • Funds reported $21.7M of ProShares Ultra NASDAQ Biotechnology stock for Q3 2017, down 17% quarter-over-quarter.
  • 8 funds opened new ProShares Ultra NASDAQ Biotechnology positions in Q3 2017 and 5 closed out, a net change of +3 holders.
  • The largest ProShares Ultra NASDAQ Biotechnology buyer in Q3 2017 was Geneos Wealth Management, an estimated $1.84M added.
  • The largest ProShares Ultra NASDAQ Biotechnology seller in Q3 2017 was RPG Investment Advisory, an estimated $5.02M sold.

Based on aggregated 13F filings for Q3 2017.